🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will identify baseline and/or pharmacodynamic biomarkers of resp...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT02593929
Treatments Being Tested
This is a phase 1, multicenter, open-label study evaluating the safety and ...
Status
Recruiting
Location
Global Oncology, Inc.
Start Date
2017-02-01
Trial ID
NCT03110822
Treatments Being Tested
This was to determine the efficacy, based upon overall survival, of ruxolit...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02119663
Treatments Being Tested
The purpose of this study is to determine real-world patient-reported outco...
Status
Completed
Location
Cardinal Health Specialty Solutions
Start Date
2021-08-02
Trial ID
NCT05665192
Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
Status
Active Not Recruiting
Location
University of California, Davis Comprehensive Cancer Center /ID# 221790
Start Date
2020-11-11
Trial ID
NCT04454658
Treatments Being Tested
The primary objective of this study was to collect additional safety of INC...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-16
Trial ID
NCT01493414
Treatments Being Tested
The purpose of this phase Ib/II clinical trial was to: a) evaluate the safe...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-05-08
Trial ID
NCT01787552
Haploidentical hematopoietic stem cell transplantation irrespective of the ...
Status
Recruiting
Location
RM Gorbacheva Research Institute
Start Date
2024-06-21
Trial ID
NCT06477549
Treatments Being Tested
The Philadelphia chromosome negative myeloproliferative neoplasms (MPN) com...
Status
Active Not Recruiting
Location
Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie
Start Date
2015-10
Trial ID
NCT02577926
Treatments Being Tested
This phase II trial tests whether ruxolitinib works to shrink tumors in pat...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2023-05-03
Trial ID
NCT05592015
Treatments Being Tested